NCT05541081View on ClinicalTrials.gov

Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe

NACompletedINTERVENTIONAL
Enrollment

1,005

Participants

Timeline

Start Date

January 12, 2023

Primary Completion Date

October 23, 2023

Study Completion Date

April 29, 2024

Conditions
Sexually Transmitted InfectionChlamydiaGonorrheaTrichomoniasisSyphilisHepatitis BHIV InfectionsPregnancySexually Transmitted Diseases
Interventions
DIAGNOSTIC_TEST

Point-of-care STI testing

"Testing for:~* Chlamydia and gonorrhoea using the GeneXpert platform (Cepheid)~* Trichomoniasis using the OSOM Trichomonas Rapid Test (Sekisui Diagnostics)~* HIV and syphilis using the SD BIOLINE HIV/Syphilis Duo (Abbott Diagnostics Medical Co. Ltd)~* Hepatitis B using the HBsAg2 rapid test (Abbott Diagnostics Medical Co. Ltd)"

Trial Locations (1)

Unknown

Mbare polyclinic, Harare

All Listed Sponsors
collaborator

Biomedical Research and Training Institute

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER